TriLink BioTechnologies is actively responding to the COVID-19 pandemic.Learn More >
About TriLink BioTechnologies
TriLink BioTechnologies, part of Maravai LifeSciences, is a CDMO helping life science leaders and innovators overcome challenges in the synthesis and scale-up of nucleic acids, NTPs and mRNA capping analogs with scale-up expertise and unique mRNA production capabilities, including its proprietary CleanCap® mRNA capping technology. TriLink continues to expand its cGMP and general mRNA, oligonucleotide & plasmid manufacturing capacity at its new global headquarters to support therapeutic, vaccine and diagnostic customers.
CDMO Service Solutions
Hot Start PCR & RT-PCR Reagents
Next Generation Sequencing Reagents
CleanCap® - optimized co-transcriptional capping for vaccine and therapeutic applications.